Literature DB >> 15152823

The in vivo expression of membrane-bound CD14 in periodontal health and disease.

Lijian Jin1, Lei Ren, W Keung Leung, Richard P Darveau.   

Abstract

BACKGROUND: Membrane-bound CD14 (mCD14) is a myeloid differentiation antigen expressed on monocytes/macrophages and neutrophils. It is a key molecule responsible for the innate recognition of bacteria by host cells and functions as an important receptor for bacterial lipopolysaccharide. This study investigated the in vivo expression profile and levels of mCD14 in healthy and diseased gingival tissues.
METHODS: Gingival biopsies were obtained from 24 patients with chronic periodontitis, including 22 periodontal pocket tissues, 13 clinically healthy tissues, and 18 inflamed connective tissues (i.e., granulation tissues). Gingival biopsies from seven periodontally healthy subjects were used as controls. mCD14 was detected by immunohistochemistry.
RESULTS: mCD14 was detected in 21 of 22 periodontal pocket tissues and all other categories of tissues. The mCD14-positive cells were mainly confined to the gingival epithelium-connective tissue interface. The expression levels in periodontally healthy subjects were significantly higher than in the patients. Within the patients, clinically healthy tissues showed greater levels of mCD14 than periodontal pocket tissues and granulation tissues.
CONCLUSIONS: mCD14 was commonly expressed in both healthy and diseased gingival tissues and was predominantly confined to the epithelium-connective tissue interface. The positive relationship observed between mCD14 expression levels and periodontal health may imply that mCD14 is associated with favorable host responses to bacterial challenge and contributes to maintaining periodontal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152823     DOI: 10.1902/jop.2004.75.4.578

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

Review 1.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

Review 2.  Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis.

Authors:  Sumita Jain; Richard P Darveau
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

Review 3.  The oral microbial consortium's interaction with the periodontal innate defense system.

Authors:  Richard P Darveau
Journal:  DNA Cell Biol       Date:  2009-08       Impact factor: 3.311

4.  Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.

Authors:  Asaf Wilensky; Rinat Tzach-Nahman; Lior Shapira; Gabriel Nussbaum; Jan Potempa
Journal:  J Innate Immun       Date:  2014-09-16       Impact factor: 7.349

5.  Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils.

Authors:  Sowmya A Castro; Russell Collighan; Peter A Lambert; Irundika Hk Dias; Parbata Chauhan; Charlotte E Bland; Ivana Milic; Michael R Milward; Paul R Cooper; Andrew Devitt
Journal:  Cell Death Dis       Date:  2017-03-02       Impact factor: 8.469

6.  Differential profiles of soluble and cellular toll like receptor (TLR)-2 and 4 in chronic periodontitis.

Authors:  Hawra AlQallaf; Yusuke Hamada; Steven Blanchard; Daniel Shin; Richard Gregory; Mythily Srinivasan
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

Review 7.  Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.

Authors:  Lina J Suárez; Hernan Garzón; Silie Arboleda; Adriana Rodríguez
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

8.  Periodontal CD14 mRNA expression is downregulated in patients with chronic periodontitis and type 2 diabetes.

Authors:  Dustin C Hedgpeth; Xiaoming Zhang; Junfei Jin; Renata S Leite; Joe W Krayer; Yan Huang
Journal:  BMC Oral Health       Date:  2015-11-18       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.